Here’s What the Street is Saying About Alphatec Holdings (ATEC) Post Earnings

Alphatec Holdings, Inc. (NASDAQ:ATEC) is one of the best healthcare stocks to buy for the long term. Alphatec Holdings, Inc. (NASDAQ:ATEC) received several rating updates following the release of its fiscal Q1 2026 results on May 5, with surgical revenue growing 17% and total revenue growing 14%. Canaccord cut the price target on the stock to $23 from $25 on May 7, but maintained a Buy rating on the shares, stating that the company posted an uncharacteristic miss in the quarter with its EOS business declining 18% year over year. It added that Alphatec Holdings’ (NASDAQ:ATEC) surgical business was more in line with expectations, with 21% case volume growth and 23% net new surgeon growth, but another quarter of weak rev/case growth against shifting regional/procedural/biologics mix.

The same day, Piper Sandler also cut the price target on Alphatec Holdings, Inc. (NASDAQ:ATEC), bringing it down to $14 from $25 while maintaining an Overweight rating on the shares. The firm was of the view that the company reported fiscal Q1 results below expectations, driven by a disappointing EOS quarter and softer-than-expected revenue per case on mix headwinds.

Alphatec Holdings, Inc. (NASDAQ:ATEC) designs, develops, and markets spinal fusion technology products and solutions to treat spinal disorders. The company’s offerings include intra-operative information and neuromonitoring technologies, fixation systems, access systems, interbody implants, and various biologics offerings.

While we acknowledge the risk and potential of ATEC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ATEC and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.